{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:06:35Z","timestamp":1782601595838,"version":"3.54.5"},"reference-count":12,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2010]]},"DOI":"10.1536\/ihj.51.293","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T06:06:05Z","timestamp":1281593165000},"page":"293-297","source":"Crossref","is-referenced-by-count":4,"title":["Primary Aldosteronism With Right-Dominant Heart Failure"],"prefix":"10.1536","volume":"51","author":[{"given":"Kazuro","family":"Sugishita","sequence":"first","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Muraoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kawana","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yoshimoto T, Hirata Y. Aldosterone as a cardiovascular risk hormone. Endocr J 2007; 54: 359-70. (Review)","DOI":"10.1507\/endocrj.KR-80"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(96)80009-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. McKelvie RS, Yusuf S, Pericak D, <i>et al<\/i>. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVED Pilot Study Investigators. Circulation 1999; 100: 1056-64.","DOI":"10.1161\/01.CIR.100.10.1056"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pitt B, Zannad F, Remme WJ, <i>et al<\/i>. The effect of spironolactone on morbidity or mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-17.","DOI":"10.1056\/NEJM199909023411001"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vogt B, Bochud M, Burnier M. The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Semin Nephrol 2007; 27: 529-37. (Review)","DOI":"10.1016\/j.semnephrol.2007.07.009"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watson T, Karthikeyan VJ, Lip GY, Beevers DG. Atrial fibrillation in primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2009; 10: 190-4.","DOI":"10.1177\/1470320309342734"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamaji T, Ishibashi M, Sekihara H, Takaku F, Nakaoka H, Fujii J. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J Clin Endocrinol Metab 1986; 63: 815-8.","DOI":"10.1210\/jcem-63-4-815"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hirata Y, Ishii M, Sugimoto T, <i>et al<\/i>. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Circulation 1988; 78: 1401-10.","DOI":"10.1161\/01.CIR.78.6.1401"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(87)90170-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rocco S, Opocher G, Carpen&egrave; G, Mantero F. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects. Am J Hypertens 1990; 3: 668-73.","DOI":"10.1093\/ajh\/3.9.668"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/4\/51_4_293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T06:51:49Z","timestamp":1618815109000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/4\/51_4_293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.51.293","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}